DSK Legal advises a broad range of clients, including pharma companies, drug and medical device developers, hospitals, and private equity-backed investors, on the full range of transactional matters alongside complex strategic regulatory and governance issues. The firm works with clients on cross-border transactions as well as compliance with both domestic and international regulatory regimes, most notably FDA rules, and is also able to represent throughout disputes. Key names in the team include Hemang Parekh and Gaurav Mistry, who is particularly active on cross-border transactions in the pharma space, alongside Harvinder Singh , noted for his specialism in hospital M&A. Mistry, alongside Akanksha Tiwary, is also heavily involved in promoter-side work, advising a number of healthcare administrators and experienced practitioners on investments and transactions. All lawyers mentioned are in Mumbai.
Testimonials
Collated independently by Legal 500 research team.
- 'Good firm to work with.'
Key clients
- Quality Care India Limited
- HealthQuad Fund II
- Eurofins Advinus Limited and Eurofins Advinus Biopharma Services India Private Limited
- Helmier Private Limited
- Mr. Sanjaya Mariwala, SJM Capsol Private Limited and OmniActive Healthcare Technologies Limited
- Axis Trustee Services Limited through its investment manager, Siana Capital Management LLP ("Siana Capital")
- Manash Lifestyle Private Limited ‘Purple’
- HCL Capital Private Limited
- Aytas Capital B.V.
- Deep Science India Fund
- Glamyo Technologies Private Limited
- Redcliffe Lifetech Private Limited
Work highlights
- Advised TPG backed Quality Care India Limited (“CARE”) in relation to the acquisition of 76% of the shareholding of United CIIGMA Institute of Medical Sciences Private Limited.
- Advised HealthQuad Fund II (“HealthQuad”) in relation to its primary and secondary investment in the Series A funding round of GoApptiv Private Limited.
- Advised TPG backed Quality Care India Limited (“CARE”) in relation to several acquisitions.